UNSPSC 51172503: Charcoal/ipecac

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AD900. This VA Drug Class (AD900) classifies this compound as belonging to the group ANTIDOTES/DETERRENTS, OTHER.

UNSPSC 51172503 Charcoal/ipecac is a Commodity code that in recent state and local procurement activity encompasses emergency pharmaceutical products and multi-source generic medications distributed through established wholesale channels and government health programs. State and local governments use this code to procure naloxone (opioid antidotes), drug deactivation systems, generic pharmaceuticals, and over-the-counter products for community health initiatives, pharmacy benefit programs, and multi-jurisdictional cooperative purchasing arrangements. Issuing bodies include county health departments, state health and human services commissions, and cooperative purchasing alliances that operate across multiple participating states and local jurisdictions. The scope includes both direct procurement of finished pharmaceutical units for emergency response and community distribution, and vendor contracting for manufacturers and distributors to supply products through authorized wholesale channels with compliance requirements including cGMP certification, Drug Supply Chain Security Act adherence, FDA approval, and specific insurance coverage mandates.

Activity in this code spans multiple regions with recent solicitations in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a July 26, 2023 response deadline. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer prescription program supporting self-insured employee health plans and state agencies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic pharmaceuticals and OTC products across participating state and local government facilities including Oregon, with proposals due March 26, 2026 and contract awards effective July 1, 2026. MMCAP's solicitation requires vendor pricing to three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson), commercial general liability insurance of $5,000,000 per occurrence, and products available in the marketplace by May 15, 2026.